Measuring quality of life in inflammatory bowel disease

Inflammatory Bowel Disease: From Bench to Bedside

Volumn , Issue , 2006, Pages 481-494

  Irvine, E Jan ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 4844231125     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/0-387-25808-6_24     Document Type: Chapter

References (96)

1. Travis SPL. Review article: Insurance risks for patients with ulcerative colitis or crohn's disease. Aliment Pharmacol Ther 1997; 11:51-9
2. Drossman DA, Patrick DL, Mitchell CM et al. Healthrelated quality of life in inflammatory bowel disease: Functional status and patient worries and concerns. Dig Dis Sci 1989; 34: 1379-86
3. Irvine EJ. Activity scores and quality of life indices in inflammatory bowel disease. Curr Opin Gastroenterol 1995; 11:331-6
4. Irvine EJ. Quality of life-rationale and methods for developing a disease-specific instrument for inflammatory bowel disease. Scand J Gastroenterol 1993; 28(Suppl. 199): 22-7
5. Maunder RG, Cohen Z, McLeod RS et al. Effect of intervention in inflammatory bowel disease on health-related quality of life: A critical review. Dis Colon Rectum 1995; 38: 1147-61
6. Fitzpatrick R, Fletcher A, Gore S et al. Quality of life measures in health care. I: Applications and issues in assessment. Br Med J 1992; 305: 1074-7
7. Garrett JW, Drossman DA. Health status in inflammatory bowel disease: Biological and behavioral considerations. Gastroenterology 1990; 99: 90-6
8. Guyatt GH, Feeny DH, Patrick DL. Measuring health related quality of life in chronic disease. Ann Intern Med 1993; 118:622-9
9. Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care 1989; 27(Suppl.):S217-32
10. Bergner M, Bobbitt RA, Carter V-B et al The Sickness Impact Profile: Development and final revision of a health status measure. Med Care 1981; 19: 787-805
11. Ware JE, Sherbourne CD. The MOS 36 item Short Form Health Survey (SF-36). Conceptual framework and item selection. Med Care 1992: 30: 473-83
12. The EuroQol Group. EuroQol-A new facility for the measurement of health-related quality of life. Health Policy 1990;16: 199-208
13. Guyatt GH, Mitchell A, Irvine EJ et al. A new measure of health status for clinical trials in IBD. Gastroenterology 1989;96: 804-10
14. Deyo RA, Diehr P, Patrick DL. Reproducability and responsiveness of health status measures: Statistics and strategies for evaluation. Control Clin Trials 1991; 12: 142-58S.
15. Guyatt GH, Walter S, Norman G. Measuring change over time: Assessing the usefulness of evaluative instruments. J ChronDis 1987; 40: 171-8
16. Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis. Gut 1963; 4: 299-315
17. Michencr WM, Farmer RG, Mortimer EA. Long-Term prognosis of ulcerative colitis with onset in childhood or adolescence. J Clin Gastroenterol 1979; 1: 301-5
18. Farmer RG, Whclan G, Fazio VW. Long-Term follow-up of patients with crohn's disease. Gastroenterology 1985; 88: 1818-25
19. Meyers S, Walfish JS, Sachar DB, Grccnstcin AJ, Hill AG, Janowitz HD. Quality of life after surgery for crohn's disease: A psychological survey. Gastroenterology 1980; 78: 1-6
20. Mallctt SJ, Lennard-Joncs JE, Binglcy J, Gilon E. Colitis. Lancet 1978; 2: 619-21
21. Gazzard BG, Price HL, Libby GW, Dawson AM. The social toll of crohn's disease. Br Med J 1978; 2: 117-19
22. Joachim G, Milne B. The effects of inflammatory bowel disease on lifestyle. Can Nurse 1985; 81: 39-40
23. Mitchell A, Guyatt G, Singer J et al. Quality o'i life in patients with IBD. J Clin Gastroenterol 1988; 10: 306-10
24. Forget S, Issenman RM, Gold N, Irvine EJ. Assessment of functional status in children and adolescents with inflammatory bowel disease. Gastroenterology 1997; 112: A974
25. Drossman DA, Leserman J, Li Z et al. The rating form of IBD patient concerns: A new measure of health status. Psychosom Med 1991; 53: 701-12
26. Drossman DA, Leserman J, Mitchell CM et al. Health status and health care use in persons with inflammatory bowel disease: A national sample. Dig Dis Sci 1991; 36: 1746-55
27. Farmer RG, Easley KA, Farmer JM. Quality of life assessment of patients with inflammatory bowel disease. Cleve Clin J Med 1992;59:35-42
28. Grogono AW, Woodgate DJ. Index for measuring health. Lancet 1971: 1: 1024-6
29. Shivananda S, van Blankenstein M, Schouten WR, Themans B, Does E. Quality of life in crohn's disease: Results of a case-control study. Eur J Gastroenterol Hepatol 1993; 5: 919-25
30. Hendriksen C, Kreiner S, Binder V. Long term prognosis in ulcerative colitis-based on results from a regional patient group from the county of Copenhagen. Gut 1985; 26: 158-63
31. Sorensen VZ, Olsen BG, Binder V. Life prospects and quality of life in patients with crohn's disease. Gut 1987; 28: 382-5
32. Guassora AD, Kruuse C, Thomsen OO, Binder V. Quality of life study in a regional group of patients with crohn's disease. Scand J Gastroenterol 2000; 35: 1068-74
33. Munkholm P, Langholz E, Davidsen M et al. Disease activity courses in a regional cohort of crohn's disease patients. Scand J Gastroenterol 1995; 30: 699-706
34. Langholz E, Munkholm P, Davidsen M, Binder V. Course of ulcerative colitis. Analysis of changes in disease activity overyears. Gastroenterology 1994; 107: 3-11
35. Sonnenberg A. Disability and need for rehabilitation among patients with inflammatory bowel disease. Digestion 1992; 51: 168-78
36. Mayberry MK, Probert C, Srivastava E, Rhodes J, Mayberry AJF Perceived discrimination in education and employment by people with crohn's disease: A case control study of educational achievement and employment. Gut 1992; 33: 312-14
37. Eckardt VF, Lesshafift C, Kanzler G et al. Disability and health care use in patients with crohn's disease: A spouse control study. Am J Gastroenterol 1994; 89: 2157-62
38. Ferguson A, Sedgwick DM, Drummond J. Morbidity of juvenile onset inflammatory bowel disease: Effects on education and employment in early adult life. Gut 1994; 35: 665-8
39. Sagar PM, Lewis W, Holdsworth PJ et al. Quality of life after restorative proctocolectomy with a pelvic ileal reservoir compares favorably with that of patients with medically treated colitis. Dis Colon Rectum 1993; 36: 584-92
40. Martin A, Dinca M, Leone L et al. Quality of life after proctocolectomy and ileo-Anal anastomosis for severe ulcerative colitis. Am J Gastroenterol. 1998 Feb; 93: 166-9
41. Cohen RD, Brodsky AL, Hanauer SB. A comparison of the quality of life in patients with severe ulcerative colitis after total colectomy versus medical treatment with intravenous cyclosporin. Inflam Bowel Dis 1999; 5: 1-10
42. Kohler LW, Pcmberton JH, Zinsmeister AR et al. Quality of life after proctocolectomy. A comparison of Brooke ileostomy, Kock pouch, and ileal pouch anal anastomosis. Gastroenterology 1991; 101: 679-84
43. Tjandra JJ, Fazio VW, Church JM, Oakley JR, Milsom JW, Lavery IC. Similar functional results after restorative proctocolectomy in patients with familial adenomatous polyposis and ulcerative colitis. Am J Surg 1993; 165: 322-5
44. Scaglia M, Bronsino E, Canino V et al. Impatto della proctocoleclomia convenzionale sulla funzione sessuale (Influence of conventional proctocolectomy on sexual function). Minerva Chir 1993; 48: 903-10
45. Moody G, Probert CS, Srivastava EM, Rhodes J, Mayberry J F Sexual dysfunction amongst women with crohn's disease: A hidden problem. Digestion 1992; 52: 179-83
46. Moody GA, Mayberry JF. Perceived sexual dysfunction amongst patients with inflammatory bowel disease. Digestion 1993; 54: 256-60
47. Colombel JF, Yazdanpanah Y, Laurent F, Houcke P, Delas N, Marquis P. Qualite de vie dans les maladies inflammatoires chroniques de Íintestin. Gastroenterol Clin Biol 1996; 20: 10771-77
48. Richards DM, Irving, MH. Assessing the quality of Hfe of patients with intestinal failure on home parenteral nutrition. Gut 1997;40:218-22
49. Mughal M, Irving M. Home parenteral nutrition in the United Kingdom and Ireland. Lancet 1986; 2: 383-7
50. Galandiuk S, O'Neill M, McDonald P, Fazio VW, Steiger E. A century of home parenteral nutrition for crohn's disease. Am J Surg 1990; 159: 540-4; discussion 544-5
51. Detsky AS, McLaughlin JR, Abrams HB et al. Quality of life of patients on long-Term total parenteral nutrition at home. J Gen Intern Med 1986; 1: 26-33
52. Nissan A, Zamir O, Spira R, Seror D, Alweiss T et al. A more liberal approach to the surgical treatment of crohn's disease. Am J Surg 1997; 174: 339-41
53. McLeod RS, Churchill DN, Lock AN, Vanderburgh S, Cohen Z. Quality of life with ulcerative colitis preoperatively and postoperatively. Gastroenterology 1991; 101: 1307-13
54. Provenzale D, Phillips-Bute B, Shearin M et al. Clinical predictors of post-colectomy health status in patients with a history of ulcerative colitis. Gastroenterology 1995; 108: A30 (Abstract
55. O'Bichere A, Wilkinson K, Rumbles S et al. Functional outcome after restorative Panproctocolectomy for ulcerative colitis decreases an otherwise enhances quahty of life. Br J Surg 2000; 87: 8802-7
56. Tiainen J, Matikainen M. Functional outcome of conversion of ileoreet al anastomosis to ileal pouch anal anastomosis in patients with familial adenomatous polyposis and ulcerative colitis. Scand J Gastroenterol 1999; 34: 601-5
57. Irvine EJ, Feagan B, Rochon J et al. Quahty of hfe: A valid and reliable measure of outcome for clinical trials in inflammatory bowel disease. Gastroenterology 1994; 106: 287-96
58. Irvine EJ, Donnelly M. Quality of life is comparably impaired in patients with ulcerative colitis and irritable bowel syndrome. Gastroenterology 1994; 106: A517
59. Love JR, Irvine EJ, Fedorak RN. Quality of life in inflammatory bowel disease. J Clin Gastroenterol 1992; 14: 15-19
60. Martin A, Naccarato R, Fries W, Leone L. Quality of hfe in inflammatory bowel disease. Ital J Gastroenterol 1995; 27: 450-4
61. Casellas F, Lopez-Vivancos J, Badia X, Vilaseca J, Malagelada Jr. Impact of surgery for crohn's disease on healthrelated quahty of life. Am J Gastroenterol 2000; 95: 177-82
62. Irvine EJ, Bolin T, Grace E et al. and the International Quality of Life Study Group. Geographic differences in health related quality of life in inflammatory bowel disease. Gastroenterology 1997; 112: A1003
63. Farrokhyar F, Marshall JK, Cawdron R, Irvine EJ. Mood disorders worsen health-related quality of life in inflammatory bowel disease. Gastroenterology 2001; 119A (In press
64. Almeida RT, Hjortsway H, Strom M, Aimer S, Persson J. Technology assessment using the association between outcome measures and patterns of illness severity. Med Biol Eng Comput 1997; 35: 386-90
65. Moser G, Tillinger W, Sachs G et al. Disease-related worries and concerns: A study on out-patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 1995; 7: 853-8
66. Lange A, Haslbeck E, Bregenzer N, Gross V, Scholmerich J, Lamparter-Lang R. Ambulatory education of crohn's disease/ ulcerative colitis. Z Gastroenterol 1996; 34: 411-15
67. Maunder RG, de Rooey EC, Toner BB et al. Health-related concerns of people who receive psychological support for inflammatory bowel disease. Can J Gastroenterol 1997; 11: 681-5
68. Provenzale D, Shearin M, Phillips-Bute BG et al. Health related quality of life after ileoanal pull-Through: Evaluation and assessment of new health status measures. Gastroenterology 1997; 113:7-14
69. Tilhnger W, Mittermaier C, Lochs H, Moser G Healthrelated quality of life in patients with crohn's disease. Influence of surgical operation-A prospective trial. Dig Dis Sci 1999; 44: 932-8
70. Robinson M, Hanauer S, Hoop R et al. Mesalamine capsules enhance the quality of life for patients with ulcerative colitis. Aliment Pharmacol Ther 1994; 8: 27-34
71. Singleton JW, Hanauer S, Robinson M. Quality of life results of a double-blind placebo controlled trial of mesalamine in patients with crohn's disease. Dig Dis Sci 1995; 40: 931-5
72. Gasche C, Dejaco C, Waldhoer T et al. Intravenous iron and erythropoietin for anemia associated with crohn's disease. Ann Intern Med 1997; 126: 782-7
73. Thomsen OO, Cortot A, Jewell D et al. A comparison of budesonide and mesalamine for active crohn's disease. N Engl J Med. 1998; 339: 370-374
74. Dupuy HJ. The Psychological General Weil-Being (PGWB) Index. In: Wenger NK, Masson ME, Furberg CD, Elinson J, eds. Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. New York: Le Lacq, 1984: 170-83
75. Martin F, Sutherland L, Beck IT et al. Oral 5ASA versus prednisone in short term treatment of crohn's disease: A multicentre controUed trial. Can J Gastroenterol 1990; 4: 452-58
76. Greenberg GR, Feagan BG, Martin FM et al. Oral budesonide for active crohn's disease. N Engl J Med 1994; 331: 836-41
77. Feagan BG, Rochon J, Fedorak RN et al. Methotrexate for the treatment of crohn's disease. N Engl J Med 1995; 332: 292-7
78. Targan S, Hanauer SB, Van Deventer SJH et al. A shortterm study of chimeric monoclonal antibody cA2 to tumor necrosis factor a for crohn's disease. N Engl J Med 1997; 337: 1029-35
79. Rutgeerts P, D'Haens G, Targan S et al. Efficacy and safety of retreatment with anti-Tumour necrosis factor antibody (infliximab) to maintain remission in crohn's disease. Gastroenterology 1999; 117: 761-9
80. Feagan B, McDonald JWD, Rochon J et al. Chronic low dose cyclosporine in the treatment of crohn's disease. N Engl J Med 1994: 330: 1846-51
81. Irvine EJ, Feagan B, Wong C. Does self-Administration of a quality of life instrument change the results? J Clin Epidemiol 1996; 49: 1177-85
82. Irvine EJ, Zhou Q, Thompson A and the CCRPT Investigators. The short IBDQ: A quality of life instrument for community physicians managing inflammatory bowel disease. Am J Gastroenterol 1996; 91: 1571-8
83. Han SW, Gregory W, Nylander D et al. The SIBDQ: Further validation in ulcerative colitis patients. Am J Gastroenterol 2000; 95: 145-51
84. North CS, Alpers DH. A review of studies of psychiatric factors in crohn's disease. Ann Clin Psychiatry 1994; 6: 117-24
85. North CS, Clouse RE, Spitznagel EL, Alpers DH. The relation of ulcerative colitis to psychiatric factors: A review of findings and methods. Am J Psychiatry 1990; 147: 974-8
86. Turnbull GK, Vallis TM. Quality of life in inflammatory bowel disease: The interaction of disease activity with psychosocial function. Am J Gatroenterol 1995; 90: 1450-4
87. Kinash RG, Fischer DG, Lukie BE, Carr TL. Inflammatory bowel disease impact and patient characteristics. Gastroenterol Nurs 1993; Feb: 147-55
88. Levenstein S, Prantera C, Varvo V et al. Psychological stress and disease activity in ulcerative colitis: A multidimensional cross-sectional study. Am J Gastroenterol 1994; 89: 1219-25
89. Levenstein S, Prantera C, Varvo V et al. Stress and exacerbation in ulcerative colitis: A prospective study of patients enrofled in remission. Am J Gastroenterol 2000; 95: 1213-20
90. Katon W Editorial: The impact of major depression on chronic medical illness. Gen Hosp Psychiatry 1996; 18: 215-19
91. Russel MG, Nieman FH, Bergers JM, Stockbrugger RW Cigarette smoking and quality of life in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 1996; 8: 1075-81
92. Eisen GM, Straus WL, Sandler RS et al. Health status in crohn's disease: Comparison of the rating form of IBD patient concerns in African and non-African Americans. Gastroenterology 1996; 110: A15
93. Straus WL, Eisen GM, Sandler RS et al. Race and crohn's disease: Clinical and therapeutic comparison of African Americans and non-African Americans. Report of a multicenter survey. Gastroenterology 1996; 110: A1021
94. Straus WL, Eisen GM, Sandler RS, Murray SC, Sessions JT. crohn's disease: Does race matter? Am J Gastroenterol 2000; 95: 479-83
95. Drummond HE, Ghosh S, Ferguson A, Brackenridge D, Tiplady B. Electronic quality of life questionnaires: A comparison of pen-based electronic questionnaires with conventional paper in a gastrointestinal study. Qual Life Res 1995; 4: 21-6
96. Kennedy AP, Thompson DG, Robinson AJ, Wilkin D. Randomized controlled trial of a patient-centred guidebook; effect on quality of life in ulcerative colitis. Gastroenterology 2000; 118(Suppl.2): A213